Gemcitabine Hydrochloride - NDC drug/product
NDCs and labelers of "Gemcitabine Hydrochloride":
| NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
|---|---|---|---|---|
| 16729-0092 | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | YES | No later than 2024-06-26 |
| 16729-0117 | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | YES | No later than 2024-06-26 |
| 16729-0118 | GEMCITABINE HYDROCHLORIDE | Accord Healthcare Inc. | YES | No later than 2024-06-26 |
| 45963-0620 | gemcitabine hydrochloride | Actavis Pharma, Inc. | YES | 2020-03-31 |
| 45963-0619 | gemcitabine hydrochloride | Actavis Pharma, Inc. | YES | 2021-07-31 |
| 45963-0612 | gemcitabine hydrochloride | Actavis Pharma, Inc. | YES | 2020-10-31 |
| 68001-0282 | Gemcitabine Hydrochloride | BluePoint Laboratories | YES | No later than 2021-09-22 |
| 69097-0314 | GEMCITABINE HYDROCHLORIDE | Cipla USA Inc. | YES | No later than 2022-03-22 |
| 69097-0313 | GEMCITABINE HYDROCHLORIDE | Cipla USA Inc. | YES | No later than 2022-03-22 |
| 68083-0149 | gemcitabine hydrochloride | Gland Pharma Limited | NO | |
| 68083-0148 | gemcitabine hydrochloride | Gland Pharma Limited | NO | |
| 42236-0002 | Gemcitabine Hydrochloride | hameln rds gmbh | YES | No later than 2017-12-29 |
| 42236-0001 | Gemcitabine Hydrochloride | hameln rds gmbh | YES | No later than 2017-12-29 |
| 23155-0213 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2020-09-01 |
| 23155-0214 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2020-09-01 |
| 23155-0483 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2019-12-28 |
| 23155-0484 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2019-12-28 |
| 23155-0528 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2019-12-28 |
| 23155-0529 | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | YES | No later than 2019-12-28 |
| 67457-0462 | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | YES | 2021-04-30 |
| 67457-0463 | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | YES | No later than 2021-09-22 |
| 67457-0464 | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | YES | 2018-08-31 |
| 00069-3858 | Gemcitabine Hydrochloride | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
| 00069-3859 | Gemcitabine Hydrochloride | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
| 00069-3857 | Gemcitabine Hydrochloride | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
| 00703-5778 | Gemcitabine Hydrochloride | Teva Parenteral Medicines, Inc. | YES | No later than 2015-06-29 |
| 00703-5775 | Gemcitabine Hydrochloride | Teva Parenteral Medicines, Inc. | YES | No later than 2015-06-29 |
| 82511-0008 | Gemcitabine hydrochloride | Teyro Labs Private Limited | NO | |
| 82511-0009 | Gemcitabine hydrochloride | Teyro Labs Private Limited | NO | |
| 00591-3563 | Gemcitabine Hydrochloride | Watson Laboratories, Inc. | YES | No later than 2019-03-18 |
| 00591-3562 | Gemcitabine Hydrochloride | Watson Laboratories, Inc. | YES | No later than 2019-03-18 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.

Quick, Current, Complete - www.findacode.com